Your browser is no longer supported. Please, upgrade your browser.
RSLS ReShape Lifesciences Inc. daily Stock Chart
ReShape Lifesciences Inc.
Index- P/E- EPS (ttm)-45.43 Insider Own2.22% Shs Outstand76.92M Perf Week-14.61%
Market Cap2.92M Forward P/E- EPS next Y-2.85 Insider Trans- Shs Float61.00M Perf Month-41.54%
Income-72.20M PEG- EPS next Q-1.47 Inst Own1.50% Short Float1.98% Perf Quarter-98.35%
Sales2.80M P/S1.04 EPS this Y91.30% Inst Trans30.26% Short Ratio0.22 Perf Half Y-99.82%
Book/sh15.78 P/B0.00 EPS next Y- ROA-102.50% Target Price32.00 Perf Year-99.87%
Cash/sh0.02 P/C1.54 EPS next 5Y0.24% ROE-120.40% 52W Range0.04 - 39.00 Perf YTD-99.83%
Dividend- P/FCF- EPS past 5Y- ROI-41.10% 52W High-99.90% Beta1.77
Dividend %- Quick Ratio0.40 Sales past 5Y32.80% Gross Margin16.00% 52W Low10.86% ATR0.01
Employees83 Current Ratio0.60 Sales Q/Q600.00% Oper. Margin- RSI (14)11.82 Volatility19.46% 18.51%
OptionableNo Debt/Eq0.00 EPS Q/Q-15.40% Profit Margin- Rel Volume0.61 Prev Close0.04
ShortableYes LT Debt/Eq0.00 EarningsAug 14 AMC Payout- Avg Volume5.55M Price0.04
Recom3.00 SMA20-30.35% SMA50-90.04% SMA200-99.63% Volume417,188 Change2.11%
Sep-24-18 08:00AM  ReShape Lifesciences Announces Acceptance of Abstract to be Presented at ObesityWeek 2018 ACCESSWIRE -5.17%
Sep-21-18 08:00AM  ReShape Lifesciences Announces Poster at IFSO Annual Conference ACCESSWIRE
Sep-18-18 06:00AM  ReShape Lifesciences Announces Pricing of Public Offering ACCESSWIRE -15.88%
Sep-14-18 04:01PM  ReShape Lifesciences Announces Proposed Public Offering ACCESSWIRE +12.07%
Sep-06-18 08:00AM  ReShape Lifesciences Announces New Patent Grant Expanding its Gastric Vest Patent Portfolio ACCESSWIRE -7.55%
Aug-24-18 08:00AM  ReShape Lifesciences to Present at H.C. Wainwright 20th Annual Global Investment Conference ACCESSWIRE
Aug-14-18 04:05PM  ReShape Lifesciences Announces Second Quarter 2018 Financial Results ACCESSWIRE -6.64%
03:38PM  ReShape Lifesciences: Burning Fat Wads of Shareholders Cash InvestorPlace
02:30PM  ReShape Lifesciences, Inc. to Host Earnings Call ACCESSWIRE
Aug-10-18 11:14AM  ReShape Lifesciences Announces Termination of Underwriting Agreement for Previously-Announced Public Offering ACCESSWIRE +31.94%
Aug-07-18 11:40PM  ReShape Lifesciences Announces Pricing of Underwritten Public Offering of Common Stock ACCESSWIRE
04:01PM  ReShape Lifesciences Announces Proposed Underwritten Public Offering of Common Stock ACCESSWIRE
Aug-03-18 08:00AM  ReShape Lifesciences to Host Second Quarter 2018 Conference Call on August 14, 2018 ACCESSWIRE -14.78%
Aug-02-18 07:00AM  ReShape Lifesciences Announces Registered Direct Offering ACCESSWIRE -51.32%
Jul-31-18 08:00AM  ReShape Lifesciences Announces European Trial to Support CE-Mark of ReShape Vest PR Newswire -13.22%
Jul-11-18 09:00AM  ReShape Lifesciences Announces $2.7 Million Registered Direct Offering Priced At-the-Market PR Newswire -19.12%
Jul-10-18 08:00AM  ReShape Lifesciences Expands Intra-gastric Balloon Business to Include Brigham and Women's Hospital in Boston PR Newswire -6.42%
Jun-27-18 08:00AM  ReShape Lifesciences Announces Acceptance of Abstract to be Presented at IFSO Annual Conference PR Newswire
Jun-20-18 09:00AM  ReShape Lifesciences Announces $1.5 Million Registered Direct Offering Priced At-the-Market PR Newswire -23.15%
Jun-19-18 08:00AM  ReShape Lifesciences Receives USPTO Issue Notification for Patent Covering its ReShape Vest PR Newswire
Jun-11-18 05:56PM  Is ReShape Lifesciences Inc (NASDAQ:RSLS) Undervalued? Simply Wall St.
Jun-08-18 07:50AM  ReShape Lifesciences (RSLS) Enters Oversold Territory Zacks
Jun-07-18 09:12AM  ReShape Lifesciences Announces $1.5 Million Registered Direct Offering Priced At-the-Market PR Newswire -12.76%
Jun-06-18 08:00AM  ReShape Lifesciences Assembles World Class Scientific Advisory Board PR Newswire
Jun-05-18 08:00AM  ReShape Lifesciences Announces New Patent Grant Expanding its Bioelectronic and Neuromodulation Portfolio PR Newswire
Jun-04-18 01:57PM  ReShape Lifesciences Provides Update on FDA Letter to Health Care Providers Related to Intragastric Balloons PR Newswire -10.24%
Jun-01-18 02:32PM  ReShape Lifesciences Announces 1-for-15 Reverse Stock Split PR Newswire
May-24-18 11:23AM  ReShape Lifesciences Inc (NASDAQ:RSLS): Does The -44.76% Earnings Drop Reflect A Longer Term Trend? Simply Wall St.
08:00AM  ReShape Lifesciences to Participate at Digestive Disease Week 2018 PR Newswire
May-16-18 08:00AM  ReShape Lifesciences Trains Eleven Surgeons in Saudi Arabia PR Newswire +5.35%
May-14-18 04:04PM  ReShape Lifesciences Announces Record Revenue for First Quarter 2018 PR Newswire +6.52%
12:30PM  ReShape Lifesciences, Inc. to Host Earnings Call ACCESSWIRE
May-10-18 08:00AM  ReShape Lifesciences Announces Submission for Approval of ReShape Balloon in Canada PR Newswire +6.74%
08:00AM  Investor Expectations to Drive Momentum within Plains Group Holdings, EnteroMedics, Vanda Pharmaceuticals, Cinemark, EPR Properties, and The Estee Lauder Companies Discovering Underlying Factors of Influence GlobeNewswire
Apr-30-18 04:05PM  ReShape Lifesciences to Host First Quarter 2018 Conference Call on May 14, 2018 PR Newswire -11.51%
Apr-20-18 07:30AM  Free Post Earnings Research Report: Senseonics' Quarterly Revenues Zoomed 867% ACCESSWIRE
Apr-18-18 08:30AM  Forty Surgeons Trained on ReShape Balloon at Hands-On Course During SAGES 2018 PR Newswire
Apr-10-18 08:30AM  ReShape Lifesciences Pioneers New Bio-electronic Technology for Treatment of Type 2 Diabetes PR Newswire
Apr-03-18 08:30AM  ReShape Lifesciences Continues Expansion in Middle East with Approval of ReShape Balloon in Saudi Arabia PR Newswire +7.81%
Apr-02-18 04:01PM  ReShape Lifesciences Announces Fourth Quarter and Year End 2017 Financial Results PR Newswire -55.86%
12:00PM  ReShape Lifesciences, Inc. to Host Earnings Call ACCESSWIRE
08:30AM  ReShape Lifesciences Announces $6 Million Registered Direct Offering PR Newswire
Mar-20-18 08:00AM  ReShape Lifesciences Announces Update on Integration Efforts and Reschedules Fourth Quarter and Full Year 2017 Conference Call to April 2, 2018 PR Newswire -6.67%
Mar-16-18 08:00AM  ReShape vBloc to be Featured at the Bariatric Metabolic Surgery Standardization World Consensus Meeting PR Newswire +12.77%
Mar-09-18 08:00AM  Consolidated Research: 2018 Summary Expectations for Envision Healthcare, Taylor Morrison Home, Vertex Pharmaceuticals, ReShape Lifesciences Inc., American Axle & Manufacturing, and Lattice Semiconductor Fundamental Analysis, Key Performance Indications GlobeNewswire
Mar-08-18 08:00AM  ReShape Lifesciences to Host Fourth Quarter and Full Year 2017 Conference Call on March 22, 2018 PR Newswire
Mar-07-18 08:00AM  ReShape Lifesciences Announces Agreement with Academy Medical to Provide ReShape Balloon and ReShape vBloc to Department of Defense Facilities PR Newswire
Mar-05-18 08:00AM  ReShape LifeSciences Announces Real-World Safety and Efficacy Study Results on ReShape Balloon Published in Journal of Clinical Gastroenterology and Hepatology PR Newswire +6.92%
Feb-22-18 04:05PM  ReShape Lifesciences Technologies to be Featured at Minimally Invasive Surgery Symposium PR Newswire
Feb-01-18 07:00AM  ReShape Lifesciences Reports Preliminary Fourth Quarter and Full Year 2017 Revenue PR Newswire
Jan-25-18 08:00AM  ReShape Lifesciences Announces 2017 Weight Loss Contest Winner PR Newswire
Dec-27-17 08:49AM  ReShape Lifesciences, Inc. :RSLS-US: Earnings Analysis: Q3, 2017 By the Numbers : December 27, 2017 Capital Cube +12.50%
Dec-13-17 08:15AM  ReShape Lifesciences Announces Stocking Order from Medical Supplier in Dubai PR Newswire
Dec-04-17 08:30AM  ReShape Lifesciences Announces Coverage of ReShape Dual Balloon by Major Telecom Company PR Newswire
Nov-15-17 07:40AM  New Research Coverage Highlights Synthetic Biologics, ReShape Lifesciences, Estée Lauder, Old Republic International, Vulcan Materials, and Taylor Morrison Home Consolidated Revenues, Company Growth, and Expectations for 2018 GlobeNewswire
Nov-14-17 04:04PM  ReShape Lifesciences Announces Third Quarter 2017 Financial Results PR Newswire
Nov-03-17 08:30AM  ReShape Lifesciences Presents New Data on Obesity Technologies PR Newswire
Oct-31-17 04:05PM  ReShape Lifesciences To Host Third Quarter Conference Call On November 14, 2017 PR Newswire
ReShape Lifesciences Inc., a medical device company, focuses on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases, and other gastrointestinal disorders. Its proprietary neuroblocking technology, vBloc Therapy is designed to intermittently block the vagus nerve using electrical impulses. The company's product portfolio includes ReShape vBloc, a therapy that enables patients to feel full and eat less by intermittently blocking hunger signals on the vagus nerve; and ReShape Balloon system that uses balloon technology designed to take up room in the stomach to enable people lose weight. Its product portfolio also comprises ReShape Vest system, an investigational, minimally invasive, laparoscopically implanted medical device that wraps around the stomach to enable weight loss in obese and morbidly obese patients without permanently changing patient anatomy. The company was formerly known as EnteroMedics Inc. and changed its name to ReShape Lifesciences Inc. in October 2017. ReShape Lifesciences Inc. was founded in 2002 and is headquartered in San Clemente, California.